Infectologia
Os lockdowns contra COVID funcionam? Isto é o que se sabe depois de 2 anos.
25 Mar, 2022 | 15:58hDid the COVID lockdowns work? Here’s what we know two years on – The Conversation
Conteúdos relacionados:
[Preprint] Efetividade de 2 e 3 doses de vacinas Pfizer e CoronaVac contra COVID-19 em Hong Kong.
25 Mar, 2022 | 15:56h
Comentário no Twitter
New data from Hong Kong on Coronavac and Pfizer vaccines implicates lack of vaccination and boosters in people of advanced age, not type of vaccine, for extreme fatality rates.
2 doses: Coronavac less protective than Pfizer
3 doses: equivalent VEhttps://t.co/BSOGscPvmc pic.twitter.com/UZqYhN7zP5— Eric Topol (@EricTopol) March 23, 2022
M-A | Mortalidade da bacteriemia por Staphylococcus aureus.
25 Mar, 2022 | 15:31hM-A | Rastreamento da tuberculose entre pacientes HIV-positivos internados.
25 Mar, 2022 | 15:30h
Comentário no Twitter
Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis https://t.co/DqTUr2JxHy In setting where TB prevalence is > 10%, WHO now strongly recommends molecular rapid diagnostic testing in all medical inpatient PWH.
— Carlos del Rio (@CarlosdelRio7) March 24, 2022
Estudo randomizado | Tratamento com dose única de anfotericina B lipossomal para meningite por criptococo.
25 Mar, 2022 | 15:01hSingle-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário no Twitter
Cryptococcal meningitis is a major complication of HIV infection. Single-dose liposomal amphotericin B combined with flucytosine and fluconazole was noninferior to the WHO-recommended treatment and was associated with fewer adverse events. https://t.co/cg9DqSDhyN pic.twitter.com/SrKx4tDaph
— NEJM (@NEJM) March 23, 2022
Estudo randomizado | Posição prona em pacientes não intubados não melhorou os desfechos em pacientes com hipoxemia moderada relacionada à Covid-19.
25 Mar, 2022 | 14:58hEditorial: Awake prone positioning for patients with covid-19
Comunicado de imprensa: Lying prone long enough to improve outcomes is difficult for many covid-19 patients – BMJ
Estudo randomizado | Segurança e eficácia da terceira dose de vacina da Pfizer contra Covid-19 durante a onda Delta.
25 Mar, 2022 | 14:56hSafety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine – New England Journal of Medicine
Comentário no Twitter
A third dose of the BNT162b2 vaccine administered a median of 10.8 months after the second dose provided 95.3% efficacy against Covid-19 as compared with two doses. #COVID19 #IDTwitter https://t.co/IeHOgVhU8a pic.twitter.com/wValXSdyHX
— NEJM (@NEJM) March 23, 2022
Estudo de caso-controle | Efetividade da vacina da Pfizer contra COVID-19 em adolescentes.
25 Mar, 2022 | 14:55hEffectiveness of BNT162b2 against COVID-19 in adolescents – The Lancet Infectious Diseases
Comentário no Twitter
Our paper on #COVID19 vaccine effectiveness in teenagers (12-17y) is published @TheLancetInfDis. Rapid waning of protection against symptomatic disease, esp with omicron. Vaccines did reduce delta hospitalisations but too early to assess omicron effects
— Shamez Ladhani (@ShamezLadhani) March 23, 2022
Revisão sistemática | Efetividade e segurança da oximetria de pulso no monitoramento remoto de pacientes com COVID-19.
25 Mar, 2022 | 14:54hComentários:
Simple home oxygen monitors signal when to seek COVID care – CIDRAP